These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

528 related items for PubMed ID: 7524798

  • 1. Results of the North American trial of piperacillin/tazobactam compared with clindamycin and gentamicin in the treatment of severe intra-abdominal infections. Investigators of the Piperacillin/Tazobactam Intra-abdominal Infection Study Group.
    Eur J Surg Suppl; 1994; (573):61-6. PubMed ID: 7524798
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prospective randomized study of piperacillin/tazobactam therapy of surgically treated intra-abdominal infection. The Piperacillin/Tazobactam Intra-Abdominal Infection Study Group.
    Polk HC, Fink MP, Laverdiere M, Wilson SE, Garber GE, Barie PS, Hebert JC, Cheadle WG.
    Am Surg; 1993 Sep; 59(9):598-605. PubMed ID: 8396374
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A randomized controlled trial of ampicillin plus sulbactam vs. gentamicin plus clindamycin in the treatment of intraabdominal infections: a preliminary report. Study Group of Intraabdominal Infections.
    Rev Infect Dis; 1986 Sep; 8 Suppl 5():S583-8. PubMed ID: 2879345
    [Abstract] [Full Text] [Related]

  • 10. Piperacillin-tazobactam treatment for severe intra-abdominal infections.
    Legrand JC, Bastin F, Belva P, Chastel C, Renaux J, Van Eukem P.
    Acta Chir Belg; 1995 Sep; 95(3):162-5. PubMed ID: 7610751
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of piperacillin/tazobactam in skin and soft tissue infections.
    File TM, Tan JS.
    Eur J Surg Suppl; 1994 Sep; (573):51-5. PubMed ID: 7524796
    [Abstract] [Full Text] [Related]

  • 12. Population pharmacokinetics and pharmacodynamics of piperacillin/tazobactam in patients with complicated intra-abdominal infection.
    Li C, Kuti JL, Nightingale CH, Mansfield DL, Dana A, Nicolau DP.
    J Antimicrob Chemother; 2005 Aug; 56(2):388-95. PubMed ID: 16002420
    [Abstract] [Full Text] [Related]

  • 13. Ticarcillin/clavulanate compared with clindamycin/gentamicin (with or without ampicillin) for the treatment of intra-abdominal infections in pediatric and adult patients.
    Dougherty SH, Sirinek KR, Schauer PR, Fink MP, Fabian TC, Martin DH, Wiedermann B.
    Am Surg; 1995 Apr; 61(4):297-303. PubMed ID: 7893090
    [Abstract] [Full Text] [Related]

  • 14. A randomized controlled clinical trial on piperacillin/tazobactam versus ticarcillin/clavulanic acid for the treatment of bacterial infections.
    Hou F, Li J, Gao L, Chen Y.
    Chin Med J (Engl); 1998 Nov; 111(11):1039-43. PubMed ID: 11189212
    [Abstract] [Full Text] [Related]

  • 15. The treatment of severe intra-abdominal infections: the role of piperacillin/tazobactam.
    Nord CE.
    Intensive Care Med; 1994 Jul; 20 Suppl 3():S35-8. PubMed ID: 7962987
    [Abstract] [Full Text] [Related]

  • 16. Ertapenem versus piperacillin-tazobactam for treatment of mixed anaerobic complicated intra-abdominal, complicated skin and skin structure, and acute pelvic infections.
    Tellado J, Woods GL, Gesser R, McCarroll K, Teppler H.
    Surg Infect (Larchmt); 2002 Jul; 3(4):303-14. PubMed ID: 12697078
    [Abstract] [Full Text] [Related]

  • 17. Randomized, multicenter, double-blind study of efficacy, safety, and tolerability of intravenous ertapenem versus piperacillin/tazobactam in treatment of complicated intra-abdominal infections in hospitalized adults.
    Namias N, Solomkin JS, Jensen EH, Tomassini JE, Abramson MA.
    Surg Infect (Larchmt); 2007 Feb; 8(1):15-28. PubMed ID: 17381394
    [Abstract] [Full Text] [Related]

  • 18. A randomized multicenter trial of piperacillin/tazobactam versus imipenem/cilastatin in the treatment of severe intra-abdominal infections. Swedish Study Group.
    Eklund AE, Nord CE.
    J Antimicrob Chemother; 1993 Jan; 31 Suppl A():79-85. PubMed ID: 8383657
    [Abstract] [Full Text] [Related]

  • 19. Clinafloxacin versus piperacillin-tazobactam in treatment of patients with severe skin and soft tissue infections.
    Siami G, Christou N, Eiseman I, Tack KJ, Severe Skin and Soft Tissue Infections Study Group.
    Antimicrob Agents Chemother; 2001 Feb; 45(2):525-31. PubMed ID: 11158750
    [Abstract] [Full Text] [Related]

  • 20. Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin-tazobactam/amoxicillin-clavulanate.
    Lipsky BA, Giordano P, Choudhri S, Song J.
    J Antimicrob Chemother; 2007 Aug; 60(2):370-6. PubMed ID: 17553812
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.